Showing results (221-230 of 483) with videos related to
Sort By:
Pageof 49
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 20, 2014
Angiopoietin-2 and outcome in patients with acute decompensated heart failureJanine Pöss, Christian Ukena, Ingrid Kindermann, et al.JACC. Clinical Electrophysiology|August 22, 2020
Research in Atrial Fibrillation: A Scientometric Analysis Using the Novel Web Application SciPEDominic Millenaar, Tobias Fehlmann, Sean Scholz, et al.ESC Heart Failure|June 27, 2026
Right Ventricular to Pulmonary Artery Coupling and Clinical Outcomes after Interatrial Shunting in Heart Failure: Exploratory Analysis of the PRELIEVE studyNijad Bakhshaliyev, Emiliano Fiori, Christina Paitazoglou, et al.Journal of Hypertension|July 6, 2016
Catheter-based radio-frequency renal nerve denervation lowers blood pressure in obese hypertensive swine modelFelix Mahfoud, L Boyce Moon, Catherine A Pipenhagen, et al.JACC. Cardiovascular Interventions|May 25, 2015
Atrial Remodeling Following Catheter-Based Renal Denervation Occurs in a Blood Pressure- and Heart Rate-Independent MannerStephan H Schirmer, Marwa M Y A Sayed, Jan-Christian Reil, et al.Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 27, 2016
Impact of obstructive and central apneas on ventricular repolarisation: lessons learned from studies in man and pigsDominik Linz, Alisa Denner, Susanne Illing, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 10, 2021
Renal denervation in patients with versus without chronic kidney disease: results from the Global SYMPLICITY Registry with follow-up data of 3 yearsChristian Ott, Felix Mahfoud, Giuseppe Mancia, et al.International Journal of Cardiology|April 1, 2014
Improvement of albuminuria after renal denervationChristian Ott, Felix Mahfoud, Axel Schmid, et al.Trials|December 22, 2015
The renin-angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril in clinical trials versus routine practice: insights from the prospective EARLY registryPeter Bramlage, Roland E Schmieder, Anselm K Gitt, et al.Contemporary Clinical Trials Communications|July 14, 2021
A re-examination of the SPYRAL HTN-OFF MED Pivotal trial with respect to the underlying model assumptionsMichael Böhm, Martin Fahy, Graeme L Hickey, et al.Pageof 49